201 related articles for article (PubMed ID: 23835175)
1. Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseases.
Hu Y; Miller MM; Derman AI; Ellis BL; Monnerat RG; Pogliano J; Aroian RV
Appl Environ Microbiol; 2013 Sep; 79(18):5527-32. PubMed ID: 23835175
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic and single-dose in vivo therapeutic studies of Cry5B anthelmintic action against hookworms.
Hu Y; Zhan B; Keegan B; Yiu YY; Miller MM; Jones K; Aroian RV
PLoS Negl Trop Dis; 2012; 6(11):e1900. PubMed ID: 23145203
[TBL] [Abstract][Full Text] [Related]
3. Bacillus thuringiensis Cry5B protein as a new pan-hookworm cure.
Hu Y; Nguyen TT; Lee ACY; Urban JF; Miller MM; Zhan B; Koch DJ; Noon JB; Abraham A; Fujiwara RT; Bowman DD; Ostroff GR; Aroian RV
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):287-294. PubMed ID: 29772478
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro studies of Cry5B and nicotinic acetylcholine receptor agonist anthelmintics reveal a powerful and unique combination therapy against intestinal nematode parasites.
Hu Y; Miller M; Zhang B; Nguyen TT; Nielsen MK; Aroian RV
PLoS Negl Trop Dis; 2018 May; 12(5):e0006506. PubMed ID: 29775454
[TBL] [Abstract][Full Text] [Related]
5. Bacillus thuringiensis Cry5B protein is highly efficacious as a single-dose therapy against an intestinal roundworm infection in mice.
Hu Y; Georghiou SB; Kelleher AJ; Aroian RV
PLoS Negl Trop Dis; 2010 Mar; 4(3):e614. PubMed ID: 20209154
[TBL] [Abstract][Full Text] [Related]
6. A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum.
Cappello M; Bungiro RD; Harrison LM; Bischof LJ; Griffitts JS; Barrows BD; Aroian RV
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15154-9. PubMed ID: 17005719
[TBL] [Abstract][Full Text] [Related]
7. Bacillus thuringiensis-derived Cry5B has potent anthelmintic activity against Ascaris suum.
Urban JF; Hu Y; Miller MM; Scheib U; Yiu YY; Aroian RV
PLoS Negl Trop Dis; 2013; 7(6):e2263. PubMed ID: 23818995
[TBL] [Abstract][Full Text] [Related]
8. Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles.
Wu CC; Hu Y; Miller M; Aroian RV; Sailor MJ
ACS Nano; 2015 Jun; 9(6):6158-67. PubMed ID: 25950754
[TBL] [Abstract][Full Text] [Related]
9. The pore-forming protein Cry5B elicits the pathogenicity of Bacillus sp. against Caenorhabditis elegans.
Kho MF; Bellier A; Balasubramani V; Hu Y; Hsu W; Nielsen-LeRoux C; McGillivray SM; Nizet V; Aroian RV
PLoS One; 2011; 6(12):e29122. PubMed ID: 22216181
[TBL] [Abstract][Full Text] [Related]
10. Insights from the Structure of an Active Form of
Li J; Wang L; Kotaka M; Lee MM; Chan MK
Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548720
[TBL] [Abstract][Full Text] [Related]
11. Efficient and Scalable Process to Produce Novel and Highly Bioactive Purified Cytosolic Crystals from Bacillus thuringiensis.
Chicca J; Cazeault NR; Rus F; Abraham A; Garceau C; Li H; Atwa SM; Flanagan K; Soto ER; Morrison MS; Gazzola D; Hu Y; Liu DR; Nielsen MK; Urban JF; Ostroff GR; Aroian RV
Microbiol Spectr; 2022 Aug; 10(4):e0235622. PubMed ID: 35946940
[TBL] [Abstract][Full Text] [Related]
12. Bacillus thuringiensis DB27 produces two novel protoxins, Cry21Fa1 and Cry21Ha1, which act synergistically against nematodes.
Iatsenko I; Boichenko I; Sommer RJ
Appl Environ Microbiol; 2014 May; 80(10):3266-75. PubMed ID: 24632254
[TBL] [Abstract][Full Text] [Related]
13. Bacterial pore-forming proteins as anthelmintics.
Hu Y; Aroian RV
Invert Neurosci; 2012 Jun; 12(1):37-41. PubMed ID: 22562659
[TBL] [Abstract][Full Text] [Related]
14. Intracellular and Extracellular Expression of Bacillus thuringiensis Crystal Protein Cry5B in Lactococcus lactis for Use as an Anthelminthic.
Durmaz E; Hu Y; Aroian RV; Klaenhammer TR
Appl Environ Microbiol; 2016 Feb; 82(4):1286-94. PubMed ID: 26682852
[TBL] [Abstract][Full Text] [Related]
15. Nematode-specific cadherin CDH-8 acts as a receptor for Cry5B toxin in Caenorhabditis elegans.
Peng D; Wan D; Cheng C; Ye X; Sun M
Appl Microbiol Biotechnol; 2018 Apr; 102(8):3663-3673. PubMed ID: 29502179
[TBL] [Abstract][Full Text] [Related]
16. Structure and glycolipid binding properties of the nematicidal protein Cry5B.
Hui F; Scheib U; Hu Y; Sommer RJ; Aroian RV; Ghosh P
Biochemistry; 2012 Dec; 51(49):9911-21. PubMed ID: 23150986
[TBL] [Abstract][Full Text] [Related]
17. Bacillus thuringiensis Cry6A exhibits nematicidal activity to Caenorhabditis elegans bre mutants and synergistic activity with Cry5B to C. elegans.
Yu Z; Luo H; Xiong J; Zhou Q; Xia L; Sun M; Li L; Yu Z
Lett Appl Microbiol; 2014 Jun; 58(6):511-9. PubMed ID: 24450432
[TBL] [Abstract][Full Text] [Related]
18. A Caenorhabditis elegans glycolipid-binding galectin functions in host defense against bacterial infection.
Ideo H; Fukushima K; Gengyo-Ando K; Mitani S; Dejima K; Nomura K; Yamashita K
J Biol Chem; 2009 Sep; 284(39):26493-501. PubMed ID: 19635802
[TBL] [Abstract][Full Text] [Related]
19.
Charuchaibovorn S; Sanprasert V; Sutthanont N; Hu Y; Abraham A; Ostroff GR; Aroian RV; Jaleta TG; Lok JB; Nuchprayoon S
Am J Trop Med Hyg; 2019 Nov; 101(5):1177-1182. PubMed ID: 31516117
[TBL] [Abstract][Full Text] [Related]
20. Resistance is non-futile: resistance to Cry5B in the nematode Caenorhabditis elegans.
Barrows BD; Griffitts JS; Aroian RV
J Invertebr Pathol; 2007 Jul; 95(3):198-200. PubMed ID: 17482642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
